Frec Markets Inc’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Buy
10,345
+2,970
+40% +$128K 0.04% 511
2026
Q1
$271K Buy
7,375
+1,141
+18% +$54.1K 0.05% 468
2025
Q4
$317K Buy
+6,234
New +$319K 0.09% 220

Other funds holding NVO

Frec Markets Inc's NVO Position: Q2 2026 in Review

Frec Markets Inc increased its Novo Nordisk (NVO) stake by 40% in Q2 2026, buying an estimated $128K and bringing the position to 10,345 shares worth $496K. The position accounts for 0.04% of the portfolio, ranked #511.

Frec Markets Inc first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Frec Markets Inc held 10,345 shares of Novo Nordisk worth $496K as of Q2 2026.
  • Frec Markets Inc bought 2,970 Novo Nordisk shares in Q2 2026, an estimated $128K.
  • Novo Nordisk made up 0.04% of Frec Markets Inc's portfolio in Q2 2026, its #511 holding.
  • Frec Markets Inc first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.